Hongmei Tang
Guangzhou, 510405, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications
FMT from IBS-D Rats Impairs Intestinal Barrier Function and is Associated with Increased Intestinal Benzoic Acid and Ruminococcus Abundance.
Journal: Journal of microbiology and biotechnology
Published: February 05, 2026
Tongxie Yaofang ameliorates IBS-D by targeting the gut microbiota-derived tryptophan metabolites and AhR signaling axis.
Journal: Frontiers in microbiology
Published: January 13, 2026
β-Sitosterol as an Anti-Tumour Active Component of Herba Sarcandrae Inhibits Colorectal Cancer Progression Through Up-Regulation of TBX20.
Journal: Journal of cellular and molecular medicine
Published: March 04, 2025
Changji'an formula alleviates visceral hypersensitivity of a post-inflammatory IBS-D mouse model via NGF/TrkA signaling pathway.
Journal: BMC complementary medicine and therapies
Published: November 07, 2024
Guidelines for the clinical application of the Xihuang pill for the prevention and treatment of breast hyperplasia diseases.
Journal: Pharmaceutical biology
Published: May 21, 2024
Establishment of a UPLC-MS method for quantitative analysis of tryptophan-kynurenine metabolism in IBS-D model rats.
Journal: Journal of pharmaceutical and biomedical analysis
Published: May 07, 2024
Network pharmacology and experimental validation to explore the mechanism of Changji'an formula against irritable bowel syndrome with predominant diarrhea.
Journal: Heliyon
Published: April 07, 2024
The therapeutic effect and targets of herba Sarcandrae on breast cancer and the construction of a prognostic signature consisting of inflammation-related genes.
Journal: Heliyon
Published: December 22, 2023
SALL1 promotes proliferation and metastasis and activates phosphorylation of p65 and JUN in colorectal cancer cells.
Journal: Pathology, research and practice
Published: January 18, 2023
Last Updated: 09/26/2026